Hyperhidrosis

Drug Safety Update

December 2014: Botulinum toxin products: rare but serious risks

  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary